Cargando…
Qualitative measurement of opioid effects on pain and dyspnea: gender difference in the sensitivity
BACKGROUND: An increasing number of patients come to the operating room in use of opioid analgesics. They have different levels of tolerance to opioid effects which challenge the anesthesiologists in search of safe and effective opioid dosing perioperatively. The tested hypothesis is that simple mea...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575662/ https://www.ncbi.nlm.nih.gov/pubmed/33079325 http://dx.doi.org/10.1186/s40981-020-00391-y |
_version_ | 1783597851729723392 |
---|---|
author | Nozaki-Taguchi, Natsuko Hayashida, Taiichiro Isono, Shiroh |
author_facet | Nozaki-Taguchi, Natsuko Hayashida, Taiichiro Isono, Shiroh |
author_sort | Nozaki-Taguchi, Natsuko |
collection | PubMed |
description | BACKGROUND: An increasing number of patients come to the operating room in use of opioid analgesics. They have different levels of tolerance to opioid effects which challenge the anesthesiologists in search of safe and effective opioid dosing perioperatively. The tested hypothesis is that simple measures introduced will allow us to measure tolerance qualitatively. Opioid effects on pain (analgesia) and dyspnea sensations (relieving effect) are tested. Patients were allocated to three groups according to pre-operative analgesics: (1) control, without any opioid analgesics, (2) weak opioid, and (3) strong opioid. Pressure pain threshold (PPT) and no-respiratory sensation period (NRSP) were measured at two points: before and 3 min after intravenous fentanyl administration. RESULTS: A total of 58 (43 controls, 9 weak opioids, and 6 strong opioids) patients were enrolled. PPT and NRSP, after iv 2 μg/kg ideal body weight (IBW) fentanyl, were significantly elevated in the control patients (PPT: 6.2 ± 2.1 N to 9.2 ± 3.9 N, p < 0.0001, NRSP: 17.8 ± 10.8 s to 22.8 ± 18.7 s, p < 0.005, paired t test). However, preoperative opioid use, though with tendency, did not show a significant decrease of the opioid effect. Due to an insufficient number of participants, no conclusion could be drawn. Further analysis of the data from control patients showed a significant difference between the two sexes in sensitivity to PPT and NRSP, as well as fentanyl effect on PPT. CONCLUSIONS: Current data showed a simple method of measuring the opioid effect on two dimensions: pain and respiration. Though not able to show a qualitative measurement of tolerance formation in opioid-users, data from control patients showed females to be more sensitive to pain and dyspnea but is less sensitive to the opioid effect. Further studies are necessary to show whether these gender differences serve as clinical relevance. TRIAL REGISTRATION: UMIN, UMIN 000011580. Registered 27 August 2013, https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr.cgi?function=brows&action=brows&type=summary&recptno=R000013352&language=J |
format | Online Article Text |
id | pubmed-7575662 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-75756622020-10-22 Qualitative measurement of opioid effects on pain and dyspnea: gender difference in the sensitivity Nozaki-Taguchi, Natsuko Hayashida, Taiichiro Isono, Shiroh JA Clin Rep Clinical Research Article BACKGROUND: An increasing number of patients come to the operating room in use of opioid analgesics. They have different levels of tolerance to opioid effects which challenge the anesthesiologists in search of safe and effective opioid dosing perioperatively. The tested hypothesis is that simple measures introduced will allow us to measure tolerance qualitatively. Opioid effects on pain (analgesia) and dyspnea sensations (relieving effect) are tested. Patients were allocated to three groups according to pre-operative analgesics: (1) control, without any opioid analgesics, (2) weak opioid, and (3) strong opioid. Pressure pain threshold (PPT) and no-respiratory sensation period (NRSP) were measured at two points: before and 3 min after intravenous fentanyl administration. RESULTS: A total of 58 (43 controls, 9 weak opioids, and 6 strong opioids) patients were enrolled. PPT and NRSP, after iv 2 μg/kg ideal body weight (IBW) fentanyl, were significantly elevated in the control patients (PPT: 6.2 ± 2.1 N to 9.2 ± 3.9 N, p < 0.0001, NRSP: 17.8 ± 10.8 s to 22.8 ± 18.7 s, p < 0.005, paired t test). However, preoperative opioid use, though with tendency, did not show a significant decrease of the opioid effect. Due to an insufficient number of participants, no conclusion could be drawn. Further analysis of the data from control patients showed a significant difference between the two sexes in sensitivity to PPT and NRSP, as well as fentanyl effect on PPT. CONCLUSIONS: Current data showed a simple method of measuring the opioid effect on two dimensions: pain and respiration. Though not able to show a qualitative measurement of tolerance formation in opioid-users, data from control patients showed females to be more sensitive to pain and dyspnea but is less sensitive to the opioid effect. Further studies are necessary to show whether these gender differences serve as clinical relevance. TRIAL REGISTRATION: UMIN, UMIN 000011580. Registered 27 August 2013, https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr.cgi?function=brows&action=brows&type=summary&recptno=R000013352&language=J Springer Berlin Heidelberg 2020-10-20 /pmc/articles/PMC7575662/ /pubmed/33079325 http://dx.doi.org/10.1186/s40981-020-00391-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Clinical Research Article Nozaki-Taguchi, Natsuko Hayashida, Taiichiro Isono, Shiroh Qualitative measurement of opioid effects on pain and dyspnea: gender difference in the sensitivity |
title | Qualitative measurement of opioid effects on pain and dyspnea: gender difference in the sensitivity |
title_full | Qualitative measurement of opioid effects on pain and dyspnea: gender difference in the sensitivity |
title_fullStr | Qualitative measurement of opioid effects on pain and dyspnea: gender difference in the sensitivity |
title_full_unstemmed | Qualitative measurement of opioid effects on pain and dyspnea: gender difference in the sensitivity |
title_short | Qualitative measurement of opioid effects on pain and dyspnea: gender difference in the sensitivity |
title_sort | qualitative measurement of opioid effects on pain and dyspnea: gender difference in the sensitivity |
topic | Clinical Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575662/ https://www.ncbi.nlm.nih.gov/pubmed/33079325 http://dx.doi.org/10.1186/s40981-020-00391-y |
work_keys_str_mv | AT nozakitaguchinatsuko qualitativemeasurementofopioideffectsonpainanddyspneagenderdifferenceinthesensitivity AT hayashidataiichiro qualitativemeasurementofopioideffectsonpainanddyspneagenderdifferenceinthesensitivity AT isonoshiroh qualitativemeasurementofopioideffectsonpainanddyspneagenderdifferenceinthesensitivity |